Elon Musk’s Neuralink seeks to enroll three patients in brain implant study
Neuralink, Elon Musk’s brain-chip company, aims to enroll three patients to evaluate its device in a study expected to take several years to complete, according to details on the U.S. government’s clinical trials database.
More in IT
